Diversified Healthcare Trust
NASDAQ:DHCREIT - Healthcare Facilities
+$0.25 today
- Market cap
- $1.76B
- Beta
- 2.29
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.33
- Dividend yield
- 0.45%
Volume 1.69M
Average 1.79M
DHC Operating Cash Flow
Cash generated by the company's core business operations during the period.
Diversified Healthcare TrustNASDAQ: DHC
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow turns positive
Q1 FY2026 operating cash flow was $8.34M, compared with -$3.24M a year earlier. Trailing-twelve-month operating cash flow was -$8.03M. Over 3 fiscal years it compounded at -21.4% a year.
Context
- Operating cash flow amounted to 1.3% of revenue in FY2025, down 6.2 pp from a year earlier.
- Operating cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly operating cash flow holds near $8.34M or moves back toward the trailing-twelve-month quarterly average of -$2.01M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (19.62M) USD
- Year-over-year change
- -117.5%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (19.62M) | -117.5% |
| FY2024 | 2024-12-31 | 112.22M | +970.5% |
| FY2023 | 2023-12-31 | 10.48M | +126.0% |
| FY2022 | 2022-12-31 | (40.35M) | +36.3% |
| FY2021 | 2021-12-31 | (63.32M) | — |
Operating Cash Flow vs competitors
How DHC compares with its peers on the latest reported figures
- DHC's LTM Mar 2026 operating cash flow of $8.03M is the smallest of the 7 companies compared; the peer median is $114.59M.
- Its year-over-year change of -110.0% is the lowest of 7, against a peer median of -0.6%.
- Operating cash flow amounts to 0.5% of revenue for DHC, versus a peer median of 25.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $9.15B | +209.6% | — | 651.2% | |
| LTM Mar 2026 | $164.96M | -7.6% | -13.2% | 29.2% | |
| LTM Mar 2026 | $161.88M | +22.6% | -40.7% | 22.6% | |
| LTM Mar 2026 | $134.73M | +3.6% | -31.1% | 16.5% | |
| LTM Mar 2026 | $94.45M | -4.9% | +2.3% | 34.8% | |
| LTM Mar 2026 | $33.58M | -89.6% | -47.8% | 4.4% | |
| LTM Mar 2026 | $8.03M | -110.0% | -21.4% | 0.5% | |
| Peer median (excluding DHC) | $114.59M | -0.6% | -31.1% | 25.9% | |
Competitors are the stored peer set for DHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 179.93M | (15.77M) | (293.57M) | (370.26M) | (285.89M) |
| Depreciation & Amortization | 263.92M | 239.53M | 283.84M | 285.06M | 262.04M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (65.12M) | 1.64M | (27.84M) | 6.82M | 33.26M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (65.12M) | 1.64M | (27.84M) | 6.82M | 33.26M |
| Other Non-Cash Items | (442.05M) | (265.74M) | 48.05M | 190.6M | (29.03M) |
| Operating Cash Flow | (63.32M) | (40.35M) | 10.48M | 112.22M | (19.62M) |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 367.03M | 108.42M | 0 | (21.18M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (124.34M) | 279.28M | (202.11M) | (165.84M) | 483.57M |
| Investing Cash Flow | 242.7M | 387.71M | (202.11M) | (187.02M) | 483.57M |
| Debt Repayment | 789.34M | (639.07M) | (217.05M) | (3.22M) | (443.54M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (383K) | (171K) | (393K) | (904K) | (1.15M) |
| Dividends Paid | (9.54M) | (9.57M) | (9.6M) | (9.63M) | (9.66M) |
| Other Financing Activities | (32.7M) | (27.19M) | (22.68M) | (8.56M) | (37.66M) |
| Financing Cash Flow | 746.72M | (676M) | (249.71M) | (22.31M) | (492.01M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 926.1M | (328.64M) | (441.34M) | (97.11M) | (28.06M) |
| Free Cash Flow | (63.32M) | (40.35M) | 10.48M | 112.22M | (19.62M) |
Diversified Healthcare Trust
NASDAQ:DHC
Intrinsic Alpha fair value
Locked
Current Price
$7.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.